These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37424127)

  • 1. Refractory Status Epilepticus and Leukoencephalopathy in an Infant With SARS-CoV-2 Infection.
    Keswani P; Kalpana D; Thomas DT; Jain N
    Indian Pediatr; 2023 Jul; 60(7):595-596. PubMed ID: 37424127
    [No Abstract]   [Full Text] [Related]  

  • 2. Super-refractory status epilepticus related to COVID-19 in a paediatric patient with PRRT2 mutation.
    Vergara D; Rubilar C; Witting S; Troncoso M; Caraballo R
    Epileptic Disord; 2021 Dec; 23(6):951-953. PubMed ID: 34668859
    [No Abstract]   [Full Text] [Related]  

  • 3. Verapamil as treatment for refractory status epilepticus secondary to PRES syndrome on a SARS-Cov-2 infected patient.
    Gómez-Enjuto S; Hernando-Requejo V; Lapeña-Motilva J; Ogando-Durán G; Fouz-Ruiz D; Domingo-García J; Rodríguez-García E; Cemillán-Fernández CA
    Seizure; 2020 Aug; 80():157-158. PubMed ID: 32574838
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of COVID-19-induced refractory status epilepticus by tocilizumab.
    Kizilkilic EK; Unkun R; Uygunoglu U; Delil S; Ozkara C
    Eur J Neurol; 2022 Sep; 29(9):2861-2863. PubMed ID: 35678591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report.
    Dono F; Carrarini C; Russo M; De Angelis MV; Anzellotti F; Onofrj M; Bonanni L
    Neurol Sci; 2021 Jan; 42(1):35-38. PubMed ID: 33145624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-COVID Syndrome (MIS-C) with Refractory Status Epilepticus.
    Kashyap H; Gupta V; Gupta A; Gupta T; Sharma S; Valjiyani S
    Indian J Pediatr; 2021 Jul; 88(7):721. PubMed ID: 33881743
    [No Abstract]   [Full Text] [Related]  

  • 7. Status epilepticus as the first symptom in a patient with coronavirus disease 2019.
    Kono Y; Sano F; Hasebe Y; Inukai T; Kaga Y
    Pediatr Int; 2023; 65(1):e15544. PubMed ID: 37243971
    [No Abstract]   [Full Text] [Related]  

  • 8. Status Epilepticus with Unilateral Brain Edema in COVID-19.
    Aso Y; Masuda T; Kimura N; Matsubara E
    Intern Med; 2024 Jul; 63(14):2103-2105. PubMed ID: 38692917
    [No Abstract]   [Full Text] [Related]  

  • 9. New-Onset Refractory Status Epilepticus in Children: Etiologies, Treatments, and Outcomes.
    Husari KS; Labiner K; Huang R; Said RR
    Pediatr Crit Care Med; 2020 Jan; 21(1):59-66. PubMed ID: 31568262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Status epilepticus: a review of current pharmacologic treatments.
    Talati R; White CM; Coleman CI
    Conn Med; 2009 Oct; 73(9):525-8. PubMed ID: 19860272
    [No Abstract]   [Full Text] [Related]  

  • 11. Atypical COVID-19-associated Non-convulsive Status Epilepticus case.
    Ioshpa M
    Isr Med Assoc J; 2023 Oct; 25(10):662-663. PubMed ID: 37846992
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute Fulminant Cerebral Edema Presenting as Refractory Status Epilepticus in a SARS-CoV-2 PCR-Positive Child without Pulmonary Involvement.
    Botre A; Otiv M; Parekar A
    Indian J Pediatr; 2023 May; 90(5):529. PubMed ID: 36823491
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute Fulminant Cerebral Edema Presenting as Refractory Status Epilepticus in a SARS-CoV-2 PCR-Positive Child Without Pulmonary Involvement: Authors' Reply.
    Botre A; Otiv M
    Indian J Pediatr; 2023 Sep; 90(9):948. PubMed ID: 37378886
    [No Abstract]   [Full Text] [Related]  

  • 14. Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus.
    Carroll E; Neumann H; Aguero-Rosenfeld ME; Lighter J; Czeisler BM; Melmed K; Lewis A
    Epilepsia; 2020 Oct; 61(10):e135-e139. PubMed ID: 32944946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Status epilepticus in a 2-month-old infant].
    Avez-Couturier J; Auvin S; Cuisset JM; Soto-Ares G; Lamblin MD; Cuvellier JC; Vallée L
    Arch Pediatr; 2006 Dec; 13(12):1540-2, 1525. PubMed ID: 16930962
    [No Abstract]   [Full Text] [Related]  

  • 16. New-onset status epilepticus in SARS-CoV-2 infection: a case series.
    Belluzzo M; Nilo A; Valente M; Gigli GL
    Neurol Sci; 2022 Mar; 43(3):2015-2020. PubMed ID: 34398369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provoked seizures and status epilepticus in a pediatric population with COVID-19 disease.
    Thongsing A; Eizadkhah D; Fields C; Ballaban-Gil K
    Epilepsia; 2022 Aug; 63(8):e86-e91. PubMed ID: 35532892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current approach to the diagnosis and treatment of refractory status epilepticus.
    Dhar R; Mirsattari SM
    Adv Neurol; 2006; 97():245-54. PubMed ID: 16383133
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrent Status Epilepticus and SARS-CoV-2 infection: the "perfect storm".
    Pauletto G; Nilo A; Deana C; Verriello L; Del Negro I; Lettieri C; Vetrugno L; Valente M; Gigli GL
    Acta Biomed; 2021 Nov; 92(5):e2021208. PubMed ID: 34738572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug resistant status epilepticus].
    Assal F; Coeytaux A; Jallon P
    Neurophysiol Clin; 2000 Jun; 30(3):139-45. PubMed ID: 10916820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.